Slide 1: ne \ Strength
ne \ Strength
Slide 2: Safe Harbor Statement
Safe Harbor This presentation contains forward-looking Statement statements (made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995). By their nature, forward- looking statements involve risk and uncertainty. Forward-looking statements represent the comp
Slide 3: Key Take Aways
Key Take Aways This document should not be distributed without Cegedim authorization – Copyright 2014 3
Slide 4: Revenue Evolution
Revenue Evolution This document should not be distributed without Cegedim authorization – Copyright 2014 4
Slide 5: Currency Impact and Business Seasonality
Currency Impact and Business Seasonality This document should not be distributed without Cegedim authorization – Copyright 2014 5
Slide 6: Revenue Evolution per Division
Revenue Evolution per Division This document should not be distributed without Cegedim authorization – Copyright 2014 6
Slide 7: CRM & Strategic Data Revenue
CRM & Strategic Data Revenue Significant currency negative impact Positive Impact from: • Emerging countries • Compliance activities • OneKey database-related products in all geographical region The market research activity experienced growth over the first 9 months This document should not be distr
Slide 8: Healthcare Professionals Revenue
Healthcare Professionals Revenue As announced, increase in Q3 revenue was mainly due to: • A less demanding comparison level for UK doctors software • Robust growth in France in products for doctors Continued positive momentum at software for pharmacists activity in France This document should not b
Slide 9: Insurance & Services Revenue
Insurance & Services Revenue Revenue increase mainly due to double digit growth at • Third-party payer flow management • Outsources payroll and HR management • Electronic and automated invoicing activities Partially offset by weakness at Cegedim Global Payment caused by the transition from a perpetu
Slide 10: GERS Activities & Reconciliation Revenue
GERS Activities & Reconciliation Revenue Continuing growth of the sales statistics business activity This document should not be distributed without Cegedim authorization – Copyright 2014 10
Slide 11: Definitive Purchase Agreement Executed
Definitive Purchase Agreement Executed This document should not be distributed without Cegedim authorization – Copyright 2014 11
Slide 12: Next Steps on IMS Health Transaction
Next Steps on IMS Health Transaction This document should not be distributed without Cegedim authorization – Copyright 2014 12
Slide 13: IMS Health Transaction: FAQ
IMS Health Transaction: FAQ This document should not be distributed without Cegedim authorization – Copyright 2014 13
Slide 14: 2014 Outlook
2014 Outlook This document should not be distributed without Cegedim authorization – Copyright 2014 14
Slide 15: Next Events
Next Events This document should not be distributed without Cegedim authorization – Copyright 2014 15
Slide 16: Our IR App is now available
Our IR App is now available This document should not be distributed without Cegedim authorization – Copyright 2014 16
Slide 17: Appendix
Appendix Innovation STRATEGY Strength ih. : eu cegedim
Slide 18: Revenue & Organic Growth Calculation
Revenue & Organic Growth Calculation CRM & Strategic Healthcare Insurance & GERS Activities & Q3‐2014 Group Data Professionals Services Reconciliation Q3 2013 Revenue a 100,193 66,016 37,617 7,188 211,014 Impact of disposals 0 0 0 0 0 Q3 2013 Revenue before impact of disposals 100,193 66,016 37,617
Slide 19: We welcome your questions and comments
We welcome your questions and comments Jan Eryk UMIASTOWSKI Chief Investment Officer Head of Investor Relations Janeryk.umiastowski@cegedim.com www.cegedim.com/finance TEL: +33 (0) 1 49 09 33 36